![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 35, 31459-31465, August 30, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
From the Discovery Research Laboratory, Tanabe Seiyaku Co. Ltd.,
2-50 Kawagishi-2-chome, Toda-shi, Saitama 335-8505, Japan
We have conducted an in silico data
base search for and cloned a novel G-protein-coupled receptor (GPCR)
named TG1019. Dot and Northern blotting analyses showed that
transcripts of the novel GPCR were expressed in various tissues except
brain, and the expression was more intense in liver, kidney, peripheral
leukocyte, lung, and spleen than in other tissues. By GTP
S binding
assay using the TG1019-G
i1-protein fusion
expressed in insect cells, eicosanoids, and polyunsaturated fatty acids
such as
5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid (5-oxo-ETE),
5(S)-hydroperoxy-6E,8Z, 11Z,14Z-eicosatetraenoic acid, and arachidonic acid were identified to exhibit agonistic activities against TG1019. 5-oxo-ETE was the most potent to enhance the
specific binding by 6-fold at a maximum effect dose of submicromolar to
micromolar order with an ED50 value of 5.7 nM.
Conversely, polyunsaturated fatty acids such as docosahexaenoic acid
and eicosapentaenoic acid showed antagonistic activities against
TG1019. In Chinese hamster ovary cells transiently expressing TG1019,
the forskolin-stimulated production of cAMP was inhibited up to ~70%
by 5-oxo-ETE, with an IC50 value of 33 nM. This
inhibition was sensitive to pretreatment of the cells with pertussis toxin.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AB083055.
Both authors contributed equally to this work.
§
To whom correspondence should be addressed. Tel.: 81-48-433-8065;
Fax: 81-48-433-8159; E-mail: t-ohnuki@tanabe.co.jp.
This article has been cited by other articles:
![]() |
P. Patel, C. Cossette, J. R. Anumolu, S. Gravel, A. Lesimple, O. A. Mamer, J. Rokach, and W. S. Powell Structural Requirements for Activation of the 5-Oxo-6E,8Z, 11Z,14Z-eicosatetraenoic Acid (5-Oxo-ETE) Receptor: Identification of a Mead Acid Metabolite with Potent Agonist Activity J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 698 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Hildebrandt Bring Your Own G Protein Mol. Pharmacol., April 1, 2006; 69(4): 1079 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Koike, H. Obinata, A. Yamamoto, S. Takeda, H. Komori, F. Nara, T. Izumi, and T. Haga 5-Oxo-Eicosatetraenoic Acid-Induced Chemotaxis: Identification of a Responsible Receptor hGPCR48 and Negative Regulation by G Protein G12/13. J. Biochem., March 1, 2006; 139(3): 543 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hardy, G. G. St-Onge, E. Joly, Y. Langelier, and M. Prentki Oleate Promotes the Proliferation of Breast Cancer Cells via the G Protein-coupled Receptor GPR40 J. Biol. Chem., April 8, 2005; 280(14): 13285 - 13291. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Almishri, C. Cossette, J. Rokach, J. G. Martin, Q. Hamid, and W. S. Powell Effects of Prostaglandin D2, 15-Deoxy-{Delta}12,14-prostaglandin J2, and Selective DP1 and DP2 Receptor Agonists on Pulmonary Infiltration of Eosinophils in Brown Norway Rats J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 64 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Monneret, R. Boumiza, S. Gravel, C. Cossette, J. Bienvenu, J. Rokach, and W. S. Powell Effects of Prostaglandin D2 and 5-Lipoxygenase Products on the Expression of CD203c and CD11b by Basophils J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 627 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mercier, C. Morin, M. Cloutier, S. Proteau, J. Rokach, W. S. Powell, and E. Rousseau 5-Oxo-ETE regulates tone of guinea pig airway smooth muscle via activation of Ca2+ pools and Rho-kinase pathway Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L631 - L640. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-R. Erlemann, J. Rokach, and W. S. Powell Oxidative Stress Stimulates the Synthesis of the Eosinophil Chemoattractant 5-Oxo-6,8,11,14-eicosatetraenoic Acid by Inflammatory Cells J. Biol. Chem., September 24, 2004; 279(39): 40376 - 40384. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Stamatiou, C.-C. Chan, G. Monneret, D. Ethier, J. Rokach, and W. S. Powell 5-Oxo-6,8,11,14-eicosatetraenoic Acid Stimulates the Release of the Eosinophil Survival Factor Granulocyte/Macrophage Colony-stimulating Factor from Monocytes J. Biol. Chem., July 2, 2004; 279(27): 28159 - 28164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vrecl, R. Jorgensen, A. Pogacnik, and A. Heding Development of a BRET2 Screening Assay Using {beta}-Arrestin 2 Mutants J Biomol Screen, June 1, 2004; 9(4): 322 - 333. [Abstract] [PDF] |
||||
![]() |
S. Takeda, T. Okada, M. Okamura, T. Haga, J. Isoyama-Tanaka, H. Kuwahara, and N. Minamino The Receptor-G{alpha} Fusion Protein as a Tool for Ligand Screening: a Model Study Using a Nociceptin Receptor-G{alpha}i2 Fusion Protein J. Biochem., May 1, 2004; 135(5): 597 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-S. Im Discovery of new G protein-coupled receptors for lipid mediators J. Lipid Res., March 1, 2004; 45(3): 410 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Brink, S.-E. Dahlen, J. Drazen, J. F. Evans, D. W. P. Hay, G. E. Rovati, C. N. Serhan, T. Shimizu, and T. Yokomizo International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor Pharmacol. Rev., March 1, 2004; 56(1): 149 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bohm, G. J. Sturm, I. Weiglhofer, H. Sandig, M. Shichijo, A. McNamee, J. E. Pease, M. Kollroser, B. A. Peskar, and A. Heinemann 11-Dehydro-thromboxane B2, a Stable Thromboxane Metabolite, Is a Full Agonist of Chemoattractant Receptor-homologous Molecule Expressed on TH2 Cells (CRTH2) in Human Eosinophils and Basophils J. Biol. Chem., February 27, 2004; 279(9): 7663 - 7670. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. ROMANO and J. CLARIA Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy FASEB J, November 1, 2003; 17(14): 1986 - 1995. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Le Poul, C. Loison, S. Struyf, J.-Y. Springael, V. Lannoy, M.-E. Decobecq, S. Brezillon, V. Dupriez, G. Vassart, J. Van Damme, et al. Functional Characterization of Human Receptors for Short Chain Fatty Acids and Their Role in Polymorphonuclear Cell Activation J. Biol. Chem., July 3, 2003; 278(28): 25481 - 25489. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zarini and R. C. Murphy Biosynthesis of 5-Oxo-6,8,11,14-eicosatetraenoic Acid from 5-Hydroperoxyeicosatetraenoic Acid in the Murine Macrophage J. Biol. Chem., March 21, 2003; 278(13): 11190 - 11196. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Jones, S. Holden, L. Tenaillon, U. Bhatia, K. Seuwen, P. Tranter, J. Turner, R. Kettle, R. Bouhelal, S. Charlton, et al. Expression and Characterization of a 5-oxo-6E,8Z,11Z,14Z-Eicosatetraenoic Acid Receptor Highly Expressed on Human Eosinophils and Neutrophils Mol. Pharmacol., March 1, 2003; 63(3): 471 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. O'Flaherty, L. C. Rogers, B. A. Chadwell, J. S. Owen, A. Rao, S. D. Cramer, and L. W. Daniel 5(S)-Hydroxy-6,8,11,14-E,Z,Z,Z-eicosatetraenoate Stimulates PC3 Cell Signaling and Growth by a Receptor-dependent Mechanism Cancer Res., December 1, 2002; 62(23): 6817 - 6819. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |